Skip to content

Long-term treatment outcomes in adults with newly diagnosed epilepsy

Long-term treatment outcomes in adults with newly diagnosed epilepsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050116
Enrollment
Unknown
Registered
2021-08-16
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy

Interventions

case series:None

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=14 years. 2. Newly diagnosed as epilepsy according to the 2017 International Anti-Epilepsy Federation (ILAE) standards. 3. Primary school education level above sixth grade, and MMSE>24. 4. Patients who have never previously used ASMs/ withdrawal medication > for 3 months. 5. Obtain the informed consent of the patient.

Exclusion criteria

Exclusion criteria: 1. Patients who failed to receive at least one efficacy/safety assessment after administration of antiepileptic drugs (ASMs). 2. Patients who are unable to cooperate or have difficulty recording seizures. 3. Poor medication compliance, that is, those who fail to take medication on time and frequently miss medication due to various reasons, those who do not follow the doctor's advice to increase or decrease the dose of medication, and those who add traditional Chinese medicine and home remedies.

Design outcomes

Primary

MeasureTime frame
mini-mental state examination,MMSE;subjective cognitive function scale,ABNAS;objective neuropsychological rating scale;epilepsy quality of life rating scale,QOLIE-31;neurological disorders depression inventory for epilepsy,NDDI-E;generalized anxiety disorder,GAD-7;Pittsburgh sleep quality index,PSQI;responder rate of anti-epileptic treatment;incidence of adverse events;seizure-free rate;radiomics data;electroencephalogram (EEG);blood electrolytes;thyroid function;blood biochemistry;medication symptom distress scale;blood fat;routine urine test;cytokine 6 items (IL 2, 4, 6, 10, TNF-a, IFN);blood concentration;

Countries

China

Contacts

Public ContactXu Huiqin

The First Affiliated Hospital of Wenzhou Medical University

xuhuiqin@wmu.edu.cn+86 13858806368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026